Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520191 · ClinicalTrials.gov registry record
Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 309
- Enrollment target
NCT04520191: Completed study, sponsored by University of New Mexico.
NCT04520191 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 309 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04520191 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
Study Summary
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic: symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).
Primary Outcome
Document COVID-19 disruptions in normal health care check-ups, transportation, economic status, and access to food and water.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2024-08-01 |
What the finished NCT04520191 record still lists
NCT04520191 is an observational study that tracks outcomes without assigning an intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04520191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04520191 about?
NCT04520191 is a clinical study titled "Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study". Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study proto...
What is the current status of trial NCT04520191?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2021-01-04. Estimated completion is 2024-08-01.
Who is sponsoring clinical trial NCT04520191?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI